| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edgewise Therapeutics, Inc. (EWTX) has 15 insiders with recent SEC Form 4 filings, including 3 buys and 9 sells. EWTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 262.5K | $9.27M | - | |
| Other | 105.0K | $3.71M | - | |
| Dir | 45.1K | $1.59M | - | |
| CEO | 38.6K | $1.36M | - | |
| Dir | 30.0K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 | Donovan Joanne M.49 | CMO | Sale+OE | 3,254 | $8.90 | $28,976.54 | -24.6% | -16.7% | +117.3% | |
| May 2, 2023 | Koch Kevin55 | President And CEO | Sale+OE | 3,203 | $8.90 | $28,522.39 | -30.8% | -16.7% | +117.3% | |
| May 2, 2023 | Carruthers R Michael48 | Chief Financial Officer | Sale+OE | 1,336 | $8.90 | $11,896.95 | -7.7% | -16.7% | +117.3% | |
| Oct 3, 2022 | Moore John R45 | General Counsel | Sale+OE | 4,730 | $9.76 | $46,154.87 | -61.2% | -9.6% | -40.1% | |
| Sep 16, 2022 | Thompson Peter A.65 | Director, 10% Owner | Buy | 484,496 | $10.32 | $4,999,998.72 | +3.6% | -18.9% | -33.0% | |
| Sep 16, 2022 | Orbimed Advisors LLC67 | Director, 10% Owner | Buy | 484,496 | $10.32 | $4,999,998.72 | +3.6% | -18.9% | -33.0% | |
| Sep 14, 2022 | Novo Holdings A/s58 | 10% Owner | Buy | 484,496 | $10.32 | $4,999,998.72 | +8.7% | -23.8% | -35.7% | |
| Sep 6, 2022 | Moore John R45 | General Counsel | Sale+OE | 4,730 | $10.91 | $51,597.72 | -36.2% | -15.8% | -38.1% | |
| Aug 3, 2022 | Moore John R45 | General Counsel | Sale+OE | 9,232 | $9.31 | $85,921.30 | -75.5% | +2.6% | -28.8% | |
| Jul 6, 2022 | Moore John R45 | General Counsel | Sale+OE | 9,232 | $8.37 | $77,256.36 | -60.6% | +23.7% | -9.1% |